RobertReiterMD

Surgical Oncology

Professor, Urology, UCLA School of Medicine

Dr. Reiter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
UCLA Medical Center
10833 LeConte Ave, 66-128 CHS
Los Angeles, CA 90095
Phone+1 310-794-7224

Fax+1 310-794-7224

Dr. Robert Reiter is an urologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from Stanford University School of Medicine and has been in practice 29 years. He also speaks multiple languages, including French and Spanish. He specializes in surgical oncology and is experienced in urologic oncology and minimally invasive urologic surgery.

Baylor College of MedicineResidency, Urology, 1990 - 1995
Stanford Health Care-Sponsored Stanford UniversityResidency, Urology, 1989 - 1990
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1988 - 1989
Stanford University School of MedicineClass of 1988

PubMed

A free method for patient-specific 3D-VR anatomical modeling for presurgical planning using DICOM images and open-source software.
Zachary Ells, Vinicius Ludwig, Adam B Weiner, Koichiro Kimura, Andrea Farolfi
Methods. 2025-04-01
Refining partial gland ablation for localised prostate cancer: the FALCON project.
Lara Rodriguez-Sanchez, Xavier Cathelineau, Theo M de Reijke, Phillip Stricker, Mark Emberton
BJU International. 2025-02-04
10 citations
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Silke Gillessen, Fabio Turco, Ian D Davis, Jason A Efstathiou, Karim Fizazi
European Urology. 2025-02-01

Journal Articles

Near-Infrared-Dye Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models
Robert Reiter, MD, Clinical Cancer Research

What Everyone Needs to Know About Prostate CancerAugust 26th, 2024
UCLA Prostate Cancer Program Receives $8.7 Million Grant from NCIOctober 31st, 2019
University Receives Prostate Cancer-Fighting GrantOctober 31st, 2019
Join now to see all